These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
307 related articles for article (PubMed ID: 34599855)
1. Impact of weight loss in patients with heart failure with preserved ejection fraction: results from the FLAGSHIP study. Kamisaka K; Kamiya K; Iwatsu K; Iritani N; Imoto S; Adachi T; Iida Y; Yamada S; ESC Heart Fail; 2021 Dec; 8(6):5293-5303. PubMed ID: 34599855 [TBL] [Abstract][Full Text] [Related]
2. Weight Loss in Obese Patients With Heart Failure. Zamora E; Díez-López C; Lupón J; de Antonio M; Domingo M; Santesmases J; Troya MI; Díez-Quevedo C; Altimir S; Bayes-Genis A J Am Heart Assoc; 2016 Mar; 5(3):e002468. PubMed ID: 27013541 [TBL] [Abstract][Full Text] [Related]
3. Prognostic impact of mineralocorticoid receptor antagonist in patients with heart failure with preserved ejection fraction. Suzuki S; Motoki H; Kanzaki Y; Maruyama T; Hashizume N; Kozuka A; Yahikozawa K; Kuwahara K ESC Heart Fail; 2020 Oct; 7(5):2752-2761. PubMed ID: 32592265 [TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics of hospitalized heart failure patients with preserved, mid-range, and reduced ejection fractions in Japan. Shiga T; Suzuki A; Haruta S; Mori F; Ota Y; Yagi M; Oka T; Tanaka H; Murasaki S; Yamauchi T; Katoh J; Hattori H; Kikuchi N; Watanabe E; Yamada Y; Haruki S; Kogure T; Suzuki T; Uetsuka Y; Hagiwara N; ESC Heart Fail; 2019 Jun; 6(3):475-486. PubMed ID: 30829002 [TBL] [Abstract][Full Text] [Related]
5. Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction. Shah AM; Cikes M; Prasad N; Li G; Getchevski S; Claggett B; Rizkala A; Lukashevich I; O'Meara E; Ryan JJ; Shah SJ; Mullens W; Zile MR; Lam CSP; McMurray JJV; Solomon SD; J Am Coll Cardiol; 2019 Dec; 74(23):2858-2873. PubMed ID: 31806129 [TBL] [Abstract][Full Text] [Related]
6. The prognostic value of highly sensitive cardiac troponin assays for adverse events in men and women with stable heart failure and a preserved vs. reduced ejection fraction. Gohar A; Chong JPC; Liew OW; den Ruijter H; de Kleijn DPV; Sim D; Yeo DPS; Ong HY; Jaufeerally F; Leong GKT; Ling LH; Lam CSP; Richards AM Eur J Heart Fail; 2017 Dec; 19(12):1638-1647. PubMed ID: 28849609 [TBL] [Abstract][Full Text] [Related]
7. Long-Term Prognostic Significance of Plasma B-Type Natriuretic Peptide Level in Patients With Acute Heart Failure With Reduced, Mid-Range, and Preserved Ejection Fractions. Hamatani Y; Nagai T; Shiraishi Y; Kohsaka S; Nakai M; Nishimura K; Kohno T; Nagatomo Y; Asaumi Y; Goda A; Mizuno A; Yasuda S; Ogawa H; Yoshikawa T; Anzai T; Am J Cardiol; 2018 Mar; 121(6):731-738. PubMed ID: 29394996 [TBL] [Abstract][Full Text] [Related]
8. Effectiveness and cost-effectiveness of serum B-type natriuretic peptide testing and monitoring in patients with heart failure in primary and secondary care: an evidence synthesis, cohort study and cost-effectiveness model. Pufulete M; Maishman R; Dabner L; Mohiuddin S; Hollingworth W; Rogers CA; Higgins J; Dayer M; Macleod J; Purdy S; McDonagh T; Nightingale A; Williams R; Reeves BC Health Technol Assess; 2017 Aug; 21(40):1-150. PubMed ID: 28774374 [TBL] [Abstract][Full Text] [Related]
9. [Prognostic value of N-terminal B-type natriuretic peptide on all-cause mortality in heart failure patients with preserved ejection fraction]. Cao J; Jin XJ; Zhou J; Chen ZY; Xu DL; Yang XC; Dong W; Li LW; Luo J; Chen L; Fu M; Zhou JM; Ge JB Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Nov; 47(11):875-881. PubMed ID: 31744276 [No Abstract] [Full Text] [Related]
10. The Hospitalization Burden and Post-Hospitalization Mortality Risk in Heart Failure With Preserved Ejection Fraction: Results From the I-PRESERVE Trial (Irbesartan in Heart Failure and Preserved Ejection Fraction). Carson PE; Anand IS; Win S; Rector T; Haass M; Lopez-Sendon J; Miller A; Teerlink JR; White M; McKelvie RS; Komajda M; Zile MR; McMurray JJ; Massie B JACC Heart Fail; 2015 Jun; 3(6):429-441. PubMed ID: 25982110 [TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of chronic obstructive pulmonary disease on adverse prognosis in hospitalized heart failure patients with preserved ejection fraction - A report from the JASPER registry. Sato Y; Yoshihisa A; Oikawa M; Nagai T; Yoshikawa T; Saito Y; Yamamoto K; Takeishi Y; Anzai T J Cardiol; 2019 Jun; 73(6):459-465. PubMed ID: 30718015 [TBL] [Abstract][Full Text] [Related]
12. Weight loss in heart failure is associated with increased mortality only in non-obese patients without diabetes. Niedziela JT; Hudzik B; Strojek K; Poloński L; Gąsior M; Rozentryt P J Cachexia Sarcopenia Muscle; 2019 Dec; 10(6):1307-1315. PubMed ID: 31397095 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of sST2 in patients with heart failure with reduced, mid-range and preserved ejection fraction. Song Y; Li F; Xu Y; Liu Y; Wang Y; Han X; Fan Y; Cao J; Luo J; Sun A; Hu K; Zhou J; Ge J Int J Cardiol; 2020 Apr; 304():95-100. PubMed ID: 32019693 [TBL] [Abstract][Full Text] [Related]
14. Prognostic value of baseline plasma amino-terminal pro-brain natriuretic peptide and its interactions with irbesartan treatment effects in patients with heart failure and preserved ejection fraction: findings from the I-PRESERVE trial. Anand IS; Rector TS; Cleland JG; Kuskowski M; McKelvie RS; Persson H; McMurray JJ; Zile MR; Komajda M; Massie BM; Carson PE Circ Heart Fail; 2011 Sep; 4(5):569-77. PubMed ID: 21715583 [TBL] [Abstract][Full Text] [Related]
15. Reductions in N-Terminal Pro-Brain Natriuretic Peptide Levels Are Associated With Lower Mortality and Heart Failure Hospitalization Rates in Patients With Heart Failure With Mid-Range and Preserved Ejection Fraction. Savarese G; Hage C; Orsini N; Dahlström U; Perrone-Filardi P; Rosano GM; Lund LH Circ Heart Fail; 2016 Nov; 9(11):. PubMed ID: 28029640 [TBL] [Abstract][Full Text] [Related]
16. Prognostic value of serum hyponatremia for outcomes in patients with heart failure with preserved ejection fraction: An observational cohort study. Su Y; Ma M; Zhang H; Pan X; Zhang X; Zhang F; Lv Y; Yan C Exp Ther Med; 2020 Nov; 20(5):101. PubMed ID: 32973950 [TBL] [Abstract][Full Text] [Related]
17. Prognostic Value of Serum Uric Acid in Hospitalized Heart Failure Patients With Preserved Ejection Fraction (from the Japanese Nationwide Multicenter Registry). Kobayashi Y; Omote K; Nagai T; Kamiya K; Konishi T; Sato T; Kato Y; Komoriyama H; Tsujinaga S; Iwano H; Yamamoto K; Yoshikawa T; Saito Y; Anzai T Am J Cardiol; 2020 Mar; 125(5):772-776. PubMed ID: 31898963 [TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of high-sensitivity cardiac troponin in patients with heart failure with preserved ejection fraction. Suzuki S; Motoki H; Minamisawa M; Okuma Y; Shoin W; Okano T; Kimura K; Ebisawa S; Okada A; Kuwahara K Heart Vessels; 2019 Oct; 34(10):1650-1656. PubMed ID: 30929038 [TBL] [Abstract][Full Text] [Related]
20. In-hospital and 1-year outcomes of acute heart failure patients according to presentation (de novo vs. worsening) and ejection fraction. Results from IN-HF Outcome Registry. Senni M; Gavazzi A; Oliva F; Mortara A; Urso R; Pozzoli M; Metra M; Lucci D; Gonzini L; Cirrincione V; Montagna L; Di Lenarda A; Maggioni AP; Tavazzi L; Int J Cardiol; 2014 May; 173(2):163-9. PubMed ID: 24630337 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]